Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

Eyal Leshem; Yehezkel Caine; Elliot Rosenberg; Yoram Maaravi; Hagai Hermesh; Eli Schwartz

doi:https://doi.org/10.1111/j.1708-8305.2012.00636.x

Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

Eyal Leshem, Yehezkel Caine, Elliot Rosenberg, Yoram Maaravi, Hagai Hermesh, Eli Schwartz

Research output: Contribution to journal › Article › peer-review

Abstract

We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06).

Original language	English
Pages (from-to)	308-310
Number of pages	3
Journal	Journal of Travel Medicine
Volume	19
Issue number	5
DOIs	https://doi.org/10.1111/j.1708-8305.2012.00636.x
State	Published - Sep 2012
Externally published	Yes

All Science Journal Classification (ASJC) codes

Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

https://doi.org/10.1111/j.1708-8305.2012.00636.x

Cite this

@article{07a3d220ffdf491faf654204bee19558,

title = "Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness",

abstract = "We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06).",

author = "Eyal Leshem and Yehezkel Caine and Elliot Rosenberg and Yoram Maaravi and Hagai Hermesh and Eli Schwartz",

year = "2012",

month = sep,

doi = "https://doi.org/10.1111/j.1708-8305.2012.00636.x",

language = "الإنجليزيّة",

volume = "19",

pages = "308--310",

journal = "Journal of Travel Medicine",

issn = "1195-1982",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

AU - Leshem, Eyal

AU - Caine, Yehezkel

AU - Rosenberg, Elliot

AU - Maaravi, Yoram

AU - Hermesh, Hagai

AU - Schwartz, Eli

PY - 2012/9

Y1 - 2012/9

N2 - We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06).

AB - We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06).

UR - http://www.scopus.com/inward/record.url?scp=84865849216&partnerID=8YFLogxK

U2 - https://doi.org/10.1111/j.1708-8305.2012.00636.x

DO - https://doi.org/10.1111/j.1708-8305.2012.00636.x

M3 - مقالة

C2 - 22943271

SN - 1195-1982

VL - 19

SP - 308

EP - 310

JO - Journal of Travel Medicine

JF - Journal of Travel Medicine

IS - 5

ER -

Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this